Close
Nordic 9Nordic 9

Evren Ucok (investor - Angel Investor)

Turkey
See something wrong or missing? Let us know
Offices:London

Evren Ucok works for Earlybird Ventures.

Average round investment:5.62M USD
Average number per year:1.0
Distribution: 2023 (1)
Portfolio companies: Belgium Amyl Therapeutics
Mostly invests in: Belgium Belgium (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Evren Ucok

Name Criteria
Germany Peppermint Venture Partners
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Social Impact Capital
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
France Anaxago
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.9
  • Active last 12 months: Yes
Belgium Inventures
72%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
Switzerland Debiopharm Innovation Fund
72%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Spain Werfen
71%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Cantos
71%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Germany Creathor Venture
71%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
France Advent France Biotechnology
70%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Norway Kvantia
70%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top